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Summary  The  2014  Beilstein  Bozen  Symposium  on  Chemistry  and  Time  was  as  diverse  in
topics, and  hence  as  difﬁcult  to  summarise  in  a  few  words,  as  all  of  its  predecessors.  We  can
all agree,  however,  that  time  is  fundamental  in  all  of  science,  affecting  everything  we  do,  andDrug  development;
Evolution;
Nanomaterials;
Fuels
everything  that  happens  in  a  chemical  system,  and  so  the  diversity  of  topics  is  just  a  reﬂection
of reality,  and  the  Symposium  in  Prien  left  all  of  its  participants  with  the  feeling  that  they  had
learned something  interesting  and  novel.
© 2015  The  Author.  Published  by  Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC  BY
license (http://creativecommons.org/licenses/by/4.0/).Contents
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he  title  of  the  article  is,  of  course,  a  play  on  the  different
eanings  of  the  word  ﬂies, but  it  is  more  relevant  to  note
hat  the  opening  word,  time, has  a  variety  of  meanings  as
ell,  and  has  many  diverse  effects  on  physical,  chemical  and
iological  processes.  It  spans  25  orders  of  magnitude,  from
he  14  billion  years  of  the  astrophysicists  to  the  femtosec-
nds  (Chapman  et  al.,  2011)  of  the  crystallographers,  and
t  every  stage  on  the  scale  it  is  relevant  to  chemistry  and
iology.  Much  of  this  range  was  discussed  during  the  2014
eilstein  Bozen  Symposium  on  Chemistry  and  Time, and  it
s  not  easy  to  summarise  it  all  succinctly.  One  thing  is  clear,
owever:  everyone  who  was  lucky  enough  to  participate  in
his  symposium  went  away  having  learned  some  interesting
nformation  that  they  did  not  know  before.
iological time
locks  and  life
n  his  lecture  Tim  Clark  described  biology  as  ‘‘stuff  happen-
ng  in  dirty  water’’,  but  those  of  us  who  are  biologists  like  to
hink  of  biology  as  more  interesting  than  that  implies,  and
ime  is  no  less  important  in  the  timescales  that  we  notice
n  living  systems  as  it  is  for  the  millions  of  years  considered
y  geologists,  astrophysicists  and  evolutionary  biologists,  or
he  femtoseconds  that  allow  structures  to  be  determined
efore  they  disintegrate.  I  shall  start  by  thinking  about  the
ost  familiar  time  scales,  from  seconds  to  days  to  years  that
eﬁne  our  everyday  lives.  All  animals  are  profoundly  inﬂu-
nced  by  time,  and  humans  are  no  exception.  We  live  by  the
lock,  but  we  sometimes  forget  the  underlying  physiology,
hinking  that  we  can  ignore  the  problems  created  by  varia-
ions  in  day  length  during  the  year,  as  well  as  those  —  more
bvious  —  caused  by  moving  through  several  time  zones  in  a
ew  hours,  made  easy  by  modern  air  travel.
Our  physiology  did  not  evolve  to  experience  artiﬁcial  light
uring  the  periods  we  wish  to  be  awake,  but  research  on  the
ature  of  sleep  and  the  effects  on  it  of  an  artiﬁcial  clock  that
gnores  changes  in  day  length  has  been  surprisingly  sparse.
espite  the  alarming  evidence  of  widespread  pathologies
ue  to  sleep-related  problems,  with  costs  believed  to
u
A
A
npproach  1%  of  gross  domestic  product  in  some  countries,
leep  research  is  barely  in  the  top  100  of  the  funding  cate-
ories  of  the  US  National  Institutes  of  Health  (Roenneberg,
013).
ircadian  rhythms
esearch  into  the  nature  of  the  circadian  clock  has,
f  course,  been  applied  for  many  years,  at  least  since
he  classic  review  of  Hess  and  Boiteux  (1971), and  pur-
ued  subsequently  by  others  (Goldbeter,  1996).  However,
hese  studies  have  been  designed  primarily  to  understand
he  biochemical  mechanisms  of  circadian  rhythms,  for
xample,  the  role  of  cycling  of  the  monosaccharide  -N-
cetylglucosamine  in  them  (Ma  and  Hart,  2014),  as  described
y  Gerald  Hart,  or  the  structure  and  function  of  cryp-
ochromes,  proteins  that  regulate  clock  genes  (Schmalen
t  al.,  2014).  Akhilesh  Reddy  described  how  some  other
roteins,  the  peroxiredoxins,  are  closely  related  to  non-
ranscriptional  mechanisms  that  contribute  to  timekeeping,
nd  their  circadian  oscillation  is  conserved  across  the  whole
ange  of  life:  bacteria,  archaea  and  eukaryotes  (Edgar  et  al.,
012).  He  explained  how  this  is  related  to  the  different
ffects  of  the  same  nutritional  intake  at  different  times  of
ay  on  human  body  weight:  better  to  consume  calories  at
reakfast  than  the  same  amount  at  dinner.
leep  research
y  contrast,  the  effects  on  health  of  interfering  with  rhythms
as  been  given  much  less  attention,  despite  the  observa-
ion  that  shift  work,  for  example,  can  greatly  increase  the
ikelihood  of  cancer  (Knutsson  et  al.,  2013),  or  that  sleep
isturbances  are  associated  with  early  Parkinson’s  disease
Breen  et  al.,  2014).  Till  Roenneberg  described  the  human
leep  project  (Roenneberg,  2013),  which  is  designed  to  ﬁll  in
ome  of  the  gaps:  it  uses  a questionnaire  to  collect  informa-
ion  from  more  than  150,000  respondents  around  the  world
bout  their  sleeping  habits,  in  the  hope  of  obtaining  a  better
nderstanding  of  the  relationship  between  sleep  and  health.
 particularly  interesting  part  concerns  the  Quilombos,  an
fro-Brazilian  population  that  is  genetically  fairly  homoge-
eous,  but  very  diverse  in  terms  of  living  habits:  some  live
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in  rural  communities  with  no  electricity,  whereas  others  live
in  modern  cities.
Ageing
A  different  aspect  of  the  physiology  of  time  comes  from
studies  of  ageing,  which  have  a  major  and  increasing  impor-
tance  for  human  health,  because,  as  Adam  Antebi  described,
Alzheimer’s  disease  is  not  only  increasing  but  is  expected
to  increase  more  steeply  than  ever  in  the  future  as  the
world  population  ages,  reaching  about  three  times  present
levels  in  the  next  40  years  (Hebert  et  al.,  2013),  and  the
incidence  of  other  forms  of  senility  is  increasing  similarly.
So  we  need  to  understand  how  the  different  stages  of  life
are  speciﬁed,  what  brings  about  the  transitions  between
them,  and  how  they  are  related  to  longevity.  The  nema-
tode  Caenorhabditis  elegans  has  proved  a  useful  model  for
studying  these  questions  (Antebi,  2013).  As  an  animal  with
a  precisely  deﬁned  set  of  cells,  and  a  normal  lifetime  short
enough  for  convenient  study  that  can  be  modiﬁed  by  vari-
ous  techniques,  it  allows  many  of  them  to  be  addressed.  For
example,  the  steroid  hormone  receptor-microRNA  switch  is
found  to  affect  timing  circuits  and  longevity.
Metabolism
Metabolism  and  time
Metabolism  is  intimately  linked  with  time,  which  plays  a
crucial  role  in  life.  On  the  one  hand  organisms  need  to
maintain  themselves  in  homeostasis  despite  frequent  and
unpredictable  changes  in  their  environment;  in  other  words
they  must  achieve  self-organisation  (Letelier  et  al.,  2011),
but  all  of  their  efforts  eventually  fail,  as  they  inevitably  age
and  ﬁnally  die.  All  of  the  metabolic  reactions  of  organisms
must  have  kinetic  and  dynamic  properties  consistent  with
their  need  to  stay  alive.
The  logic  of  metabolism
The  vast  array  of  these  reactions  can  appear  hopelessly
arbitrary  and  unmemorable  to  the  student  encountering
them  for  the  ﬁrst  time  in  elementary  biochemistry  courses.
However,  Antoine  Danchin  pointed  out  that  closer  study
reveals  a  great  deal  of  logical  organisation,  albeit  it  with
some  ‘‘historical’’  constraints  inherited  from  the  origin  of
life,  and  others  from  the  impossibility  of  achieving  total
speciﬁcity  in  enzyme-catalysed  reactions:  errors  in  follow-
ing  the  informational  rules  can  result  in  the  appearance
of  a  ‘‘shadow  metabolism’’  (Danchin  and  Sekowska,  2013).
Selenium  toxicity,  for  example,  results  from  the  ability  of
selenium  atoms  to  substitute  for  sulphur  atoms  in  some
conditions,  but  not  in  all,  but  some  bacteria  have  learned
to  use  selenocysteine  as  a  ‘‘paralogous’’  metabolite,  mak-
ing  it  the  21st  amino  acid  that  is  genetically  coded  (in
some  organisms).  A  similar  example  might  appear  to  be
the  capacity  of  arsenic  to  replace  phosphorus  in  some
reactions,  and  some  authors  have  claimed  that  arsenic-
based  life  can  be  observed  in  some  extreme  environments
(Wolfe-Simon  et  al.,  2011).  However,  this  claim  has  been
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ejected  almost  universally  by  authors  who  understand  the
nescapable  chemical  fact  that  arsenate  esters  are  far  too
abile  to  exist  for  a  signiﬁcant  time  in  cells,  for  exam-
le  some  of  my  colleagues  in  Marseilles  (Schoepp-Cothenet
t  al.,  2011).  The  notion  of  arsenic-based  life  derives  from
ailure  to  take  account  of  time  as  a  determinant  of  which
inds  of  biological  structures  are  possible.
Hiroki  Ueda  and  his  colleagues  are  applying  the  idea  of
etabolic  logic  to  circadian  clocks,  asking,  for  example,
hat  conditions  will  allow  a  temperature-insensitive  clock
Jolley  et  al.,  2012).  A  very  simple  system,  consisting  of
ust  one  enzyme  and  one  peptide  substrate,  can  produce
 temperature-insensitive  reaction,  but  it  cannot  gener-
te  oscillations.  However,  these  become  possible  with  a
lightly  more  complex  system  with  two  enzymes  (such  as  a
inase  and  a  phosphatase)  with  one  peptide  substrate,  and
t  appears  that  protein  phosphorylation  is  a limiting  step  in
he  mammalian  circadian  clock.
ailures  of  metabolic  and  signalling  pathways
o  matter  how  logical  and  well-designed  a  metabolic  system
ay  appear  to  be,  however,  it  can  never  operate  perfectly,
n  part  on  account  of  the  impossibility  of  perfect  speciﬁcity
entioned  already,  and  Dario  Alessi  pointed  out  that  most
uman  diseases  can  be  attributed  to  failures  in  signalling
athways.  Cancer,  for  example,  was  suggested  as  long  as
0  years  ago  to  be  a  metabolic  disorder  (Warburg  et  al.,
924),  but  this  has  only  become  widely  recognised  in  the
ast  decade,  in  part  as  a  result  of  the  discovery  of  the
pstream  protein  kinase  that  acts  on  the  AMP-activated  pro-
ein  kinase  as  a  complex  containing  LKB1,  a  known  tumour
uppressor  (Hawley  et  al.,  2003).  This  led  to  a  great  deal  of
urther  research,  as  recently  reviewed  (Hardie  and  Alessio,
013).  One  may  add  to  this  the  realisation  that  there  is  an
nexpected  link  between  cancer  and  metabolic  control  anal-
sis.  It  has  been  known  for  more  than  a century  than  cancer
ells  are  typically  aneuploid  (Hansemann,  1890),  with  an
ncorrect  number  of  chromosomes,  but  it  remained  far  from
bvious  why  this  might  be  related  to  the  clinical  manifes-
ations  of  cancer.  Metabolic  control  analysis,  in  contrast,
s  concerned  with  the  relationship  between  enzyme  activ-
ty  and  metabolic  ﬂuxes,  with  an  important  generalisation
hat  changing  the  activity  of  an  enzyme  typically  has  no  sig-
iﬁcant  effect  on  metabolic  ﬂux  (Kacser  and  Burns,  1973).
owever,  that  is  for  changes  in  one  or  at  least  a  small  num-
er  of  enzyme  activities;  it  is  very  different  in  an  aneuploidal
ell  in  which  many  enzymes  simultaneously  have  abnormal
oncentrations,  and  hence  abnormal  activities.  In  this  case
erious  metabolic  disturbances  can  arise  that  can,  when  they
ecome  sufﬁciently  severe,  lead  to  cancer  (Duesberg  et  al.,
001).
odelling  metabolism
ecause  of  the  large  number  of  metabolic  reactions,  most
f  them  only  poorly  characterised,  it  remains  a  huge  task  to
onstruct  a  model  of  the  whole  of  metabolism,  but  heroic
fforts  to  do  this  are  in  progress.  On  the  one  hand  there  are
 few  pathways,  such  as  glycolysis  in  the  human  erythrocyte
du  Preez  et  al.,  2008),  the  parasite  Trypanosoma  brucei
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Bakker  et  al.,  1999),  or  yeast  (Van  Eunen  et  al.,  2012),  for
hich  an  adequate  supply  of  usable  kinetic  data  is  avail-
ble,  but  these  remain  exceptional  —  a  situation  that  the
eilstein  STRENDA  initiative  (Kettner  and  Cornish-Bowden,
014)  is  striving  to  overcome  —  and  for  most  metabolic  sys-
ems  kinetic  modelling  is  a  dream  for  the  future.  Large-scale
odels,  therefore,  have  to  be  based  on  stoichiometric  infor-
ation:  knowing  which  reactions  are  present,  but  without
nowing  their  kinetics.  The  scale  of  such  an  effort  can  be
udged  from  Recon  2  (Swainston  et  al.,  2013),  a  reconstruc-
ion  of  human  metabolism  consisting  of  6852  biochemical
nd  transport  reactions  distributed  over  eight  intracellu-
ar  compartments,  2469  unique  metabolites,  and  enzymes
oded  by  1766  genes.  It  will  be  obvious  that  a  project  of
uch  magnitude  requires  input  from  many  research  groups
round  the  world,  and  for  that  reason  Neil  Swainston  and
is  colleagues  call  Recon  2  a  ‘‘community-driven’’  recon-
truction.  As  an  example  of  the  type  of  problem  that  can  be
ddressed  with  a  reconstruction  of  this  kind  one  can  mention
he  effect  of  deleting  the  gene  for  the  enzyme  fumarase  in
enal  cancer  (Frezza  et  al.,  2011).  However,  without  wishing
o  devalue  this  type  of  study  one  may  regret,  in  a  sympo-
ium  on  Chemistry  and  Time, the  absence  of  any  kinetic
nformation.
rug discovery
hy  must  metabolic  and  signalling  pathways  be  so
omplicated?
ne  of  the  ways  in  which  organisms  can  overcome  the  lack  of
erfect  speciﬁcity  in  individual  processes  is  to  evolve  more
omplicated  systems  that  involve  several  components,  and
his  is  a  major  reason  for  the  apparently  unnecessary  com-
lexity  of  living  organisms.  Tom  Blundell  pointed  out  that
raditional  ideas  of  signalling  pathways  would  give  very  noisy
 and  hence  inadequate  —  signals,  but  multi-component
rotein  assemblies  can  greatly  improve  the  signal-to-noise
atio  in  cell  regulation,  molecular  interactions  being  sta-
ilised  cooperatively  as  the  components  are  assembled  into
 signalling  complex.  This  allows  signalling  systems  to  be
oth  selective  and  reversible,  but  from  the  researcher’s
oint  of  view  it  leads  to  two  challenges  (Winter  et  al.,  2012):
ow  to  design  drugs  that  target  protein—protein  interfaces,
nd  how  to  understand  the  mechanisms  of  the  assembly.
Francesco  Gervasio  described  a  different  approach  to
nderstanding  ligand—protein  interactions,  pointing  out
hat  a  major  problem  for  modelling  binding  kinetics  is  the
ack  of  information  in  most  cases  of  the  detailed  Gibbs-
nergy  proﬁles  along  association  pathways.  An  effective
omputational  strategy  can,  however,  allow  binding  kinet-
cs  to  be  calculated  (Juraszek  et  al.,  2013),  as  well  as  the
onformational  changes  that  occur  on  binding  (Sutto  and
ervasio,  2013).
Akhilesh  Reddy’s  report  of  the  effects  of  circadian
hythms,  mentioned  already,  is  clearly  relevant  here:  the
ffectiveness  of  a  drug  must  depend  not  only  on  the  dose  but
lso  on  when  in  the  circadian  cycle  it  is  administered.  What
s  optimistically  called  rational  drug  design,  a  term  that  was
lready  treated  with  scepticism  as  long  ago  as  1966  (Belleau,
966),  is  often  pursued  with  no  consideration  of  metabolism
e
d
p
aA.  Cornish-Bowden
t  all.  For  example,  a  supplement  to  Nature  entitled
‘intelligent  drug  design’’  (Various  authors,  1996)  nowhere
ncluded  the  words  ‘‘metabolism’’  or  ‘‘metabolic’’,  and  a
imilar  special  issue  of  Science  on  drug  discovery  (Various
uthors,  2000)  was  barely  any  better  (Cárdenas  and  Cornish-
owden,  2000).  The  point  that  is  overlooked  in  these  efforts
s  that  what  (most)  drugs  do  is  to  modify  metabolism,  and
he  circadian  point  is  that  to  be  effective  they  have  to  act  on
he  metabolic  state  that  exists  at  the  time  of  administration.
etting  drugs  to  their  targets
 ﬁrst  learned  of  Lipinski’s  rules  in  a  lecture  by  Christopher
ipinski  himself  at  the  ﬁrst  Beilstein  Bozen  Symposium  that
 attended  in  2002  (Lipinski,  2002).  The  rules  had  been  ﬁrst
roposed  some  years  earlier  (Lipinski  et  al.,  1997),  and  have
een  enormously  inﬂuential  in  the  pharmaceutical  indus-
ry:  the  original  paper  has  now  been  cited  more  than  3000
imes,  with  more  than  300  in  each  of  the  years  2011—2013.
onetheless,  Douglas  Kell  has  strongly  argued  (Kell,  2013)
hat  this  approach  is  largely  misconceived,  and  that  that  is
hy  adherence  to  the  rules  has  not  been  very  effective  in
rug  discovery.  The  problem  is  that  they  allow  prediction  of
he  properties  that  allow  a  molecule  to  enter  a  cell  by  pas-
ive  diffusion,  but  that  is  not  at  all  what  one  needs  to  know,
ecause  most  effective  drugs  are  transported  into  cells  by
peciﬁc  carriers.
Trevor  Howe  argued  in  addition  that  kinetic  consider-
tions  also  needs  to  be  taken  into  account,  as  equilibrium
ssays  are  not  likely  to  be  enough.  He  described  the
nnovative  Medicines  Initiative  Kinetics  for  Drug  Discovery
rogramme,  a European  project  costing  around  21  million
uros  over  ﬁve  years,  and  involving  seven  major  drug  compa-
ies  and  ten  universities  in  four  countries  (Müller-Fahrnow,
010).  This  idea  was  developed  by  Emad  Tajkhorshid,  who
iscussed  how  membrane  transport  can  be  simulated  com-
utationally  with  high  resolution  in  both  time  and  space,  for
xample  in  ATP-binding  cassette  transporters  (Moradi  and
ajkhorshid,  2013).
anomaterials
ven  if  membrane  transporters  are  the  principal  mediators
f  active  exchange  of  materials  across  cellular  membranes,
hey  are  not  the  only  ones.  Drug  delivery  systems  do  not
ave  to  rely  on  natural  transporters,  and  nanomaterials
re  attracting  attention  as  an  alternative,  as  presented  by
athan  Gianneschi.  He  and  his  group  showed  that  active
ccumulation  of  nanoparticles  in  tumours  can  be  achieved
n  a  speciﬁc  assembly  event  that  responds  to  biochemical
ignals  associated  with  tumour  tissue  (Chien  et  al.,  2013).
It  is  impossible  to  prepare  and  test  every  conceivable  kind
f  nanoparticle,  because,  as  Dave  Winkler  said  in  his  presen-
ation,  there  are  potentially  more  drug-like  molecules  that
bey  the  laws  of  chemical  valence  than  there  are  atoms
f  matter  in  the  universe.  Instead  it  is  essential  to  have
owerful  computational  methods  that  allow  the  biological
ffects  of  potential  nanomaterials  to  be  modelled  and  pre-
icted  in  silico. For  this  we  need  to  know  not  only  the
ossible  useful  biological  effects  of  such  nanomaterials,  but
lso  any  potential  dangers  that  they  may  represent.  Novel
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sparse  machine-learning  methods  based  on  Bayesian  neural
networks  are  thus  being  developed  for  this  purpose  (Winkler
et  al.,  2014),  and  they  prove  to  have  useful  predictive  value.
Evolutionary time
Directed  evolution
As  everyone  knows,  evolution  by  natural  selection  is  excruci-
atingly  slow.  The  last  universal  common  ancestor  (‘‘LUCA’’)
of  all  extant  organisms  is  thought  to  have  existed  more  than
3  ×  109 years  ago,  but  evolution  has  been  slow  enough  to
allow  many  of  its  characteristics  to  be  deduced  from  those
of  modern  organisms.  Moreover,  natural  selection  is  a poor
algorithm  for  optimisation,  akin  to  what  computer  scientists
call  greedy  algorithms, which  work  by  making  the  best  local
choice  at  every  step,  in  the  hope  of  ﬁnding  a  global  opti-
mum,  but  with  no  vision  of  where  this  optimum  is  likely  to
be.  However,  as  argued  by  Philippe  Marlière,  not  only  are
biotechnologists  unwilling  to  wait  millions  of  years  to  arrive
at  useful  results;  they  also  believe  that  they  can  proceed
faster  by  means  of  directed  evolution  under  human  selec-
tion  and  synthetic  biology.  For  example  artiﬁcial  nucleic
acids  (Herdewijn  and  Marlière,  2012)  can  propagate  genetic
information  in  vivo  deliberately  insulated  from  the  normal
processes  of  replication  and  transcription.  Quite  apart  from
its  technological  promise,  directed  evolution  can  lead  us  to
a  better  understanding  of  how  the  genetic  code  developed:
it  can  hardly  have  coded  for  as  many  as  20  amino  acids  at
the  outset,  but  which  ones  did  it  have  and  how  did  oth-
ers  arise?  Jeffrey  Wong’s  coevolution  theory  (Wong,  2005),
which  postulates  that  ‘‘new’’  codons  were  given  to  new
amino  acids  by  their  metabolic  precursors,  probably  pro-
vides  part  of  the  answer,  but  one  can  also  study  the  question
by  asking  how  an  enzyme  that  used  only  a  few  amino  acids
could  be  improved  by  expanding  its  resources:  for  exam-
ple,  how  could  a  chorismate  mutase  with  only  nine  amino
acids  be  improved  by  allowing  it  access  to  20  (Muller  et  al.,
2013)?  This  type  of  study  has  led  to  some  surprising  results:
for  example,  one  might  expect  that  mutating  leucine  into
such  a  similar  amino  acid  as  valine  might  offer  little  advan-
tages,  but  such  apparently  innocuous  substitutions  can  be
observed  in  parallel  in  independent  evolutionary  trajecto-
ries;  this  suggests  that  even  building  blocks  with  very  similar
structures  can  be  highly  beneﬁcial  for  ﬁne-tuning  enzyme
structure  and  function.
Evolution  of  defence  mechanisms
Given  the  time  available,  many  organisms,  including  agricul-
turally  important  pests  such  as  the  leaf  beetle  Chrysomela
populi,  have  arrived  at  defence  mechanisms  against  preda-
tors,  in  which,  as  Wilhelm  Boland  described,  the  larvae  have
‘‘bioreactors’’  on  their  backs  that  discharge  droplets  of  tox-
ins  when  they  are  attacked  (Discher  et  al.,  2009).
The  green  alga  Euglena  gracilis,  familiar  to  most  people
who  have  taken  biology  practical  classes,  is  not  only  very
versatile  in  its  metabolism,  allowing  it  respond  efﬁciently
to  redox  stress,  but  also  has  a  complicated  evolutionary
history.  One  might  expect  it  to  be  closely  related  to  other
algae  and  plants,  but  in  fact  it  separated  from  quite
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ifferent  genera  of  protozoans,  the  major  pathogens  Try-
anosoma  and  Leishmania, only  80  million  years  ago.  Not
nly  that,  but  as  Robert  Field  described,  it  has  a  very  large
umber  of  protein-coding  genes,  similar  to  that  of  humans,
nd  transcriptomic  studies  are  allowing  understanding  of
ow  it  makes,  uses  and  controls  molecules  and  processes.
hemistry  as  creation  science
reationism  is  normally  regarded  as  being  in  complete  oppo-
ition  to  evolutionary  science,  and  that  is  certainly  true  if  we
estrict  attention  to  natural  biology  (Cornish-Bowden  et  al.,
014).  However,  Leroy  Cronin  pointed  out  in  his  presentation
hat  synthetic  chemistry  is  a  creationist  science:  chemists
nvisage  the  molecules  they  want  to  create  and  then  design
hem  on  the  basis  of  chemical  principles,  an  approach  com-
letely  different  from  natural  selection.  He  is  exploring  the
ossibility  of  inorganic  systems  that  can  evolve  and  provide
nsight  into  the  prebiotic  evolution  that  predated  the  world
f  nucleic  acids  (Cronin,  2013).
lectron transport and the energy crisis
ydrogen  as  a clean  fuel
he  approaching  energy  crisis  is  one  of  the  major  problems
hat  humanity  will  need  to  solve  in  the  coming  decades
f  disaster  is  to  be  avoided.  It  is  easy  to  say,  and  I  have
aid  it  myself,  that  large  savings  in  energy  can  be  made
y  adopting  less  wasteful  habits,  but,  as  Stenbjörn  Styring
ointed  out  in  his  lecture,  that  cannot  solve  the  problem:
t  can  only  save  energy  in  the  developed  countries,  whereas
any  populations  that  live  today  in  a  highly  undeveloped
tate  can  be  expected  to  increase  their  energy  require-
ents  enormously  by  2050.  Moreover,  electricity  accounts
or  only  17%  of  energy  consumption  today,  and  more  efﬁ-
ient  generation  of  electrical  power  can  only  improve  a
mall  part  of  the  problem.  Many  groups  today  are  accord-
ngly  working  on  ways  of  using  solar  energy  to  produce
ore  efﬁcient  fuels  that  can  be  oxidised  without  produc-
ng  carbon  dioxide,  most  notably  hydrogen  gas  (Magnuson
t  al.,  2009).  Attempts  to  produce  fuels  by  natural  pho-
osynthesis  in  living  organisms,  such  as  bacteria  or  algae
Matsumura  et  al.,  2014),  or  active  enzymes  obtained  from
hem  (de  Poulpiquet  et  al.,  2014),  are  attracting  consid-
rable  attention,  but  an  alternative  is  to  use  biomimetic
ethods  in  which  purely  chemical  catalysts  are  designed  on
he  principles  learned  by  studying  such  organisms  (Simmons
t  al.,  2014).
nderstanding  electron  transport
pplying  any  of  these  approaches  successfully  will  require
ncreased  understanding  of  electron  transfer  in  proteins,
he  subject  of  Israel  Pecht’s  presentation.  How  are  the
ates  of  electron  transfer  between  redox  centres  controlled,
uned  for  efﬁciency,  and  made  capable  of  avoiding  harmful
roducts?  These  aspects  can  be  probed  by  studying  model
ystems  such  as  the  bacterial  copper  proteins  azurin  and  lac-
ase,  and  examining  the  effects  of  mutations  on  rates  and
1s
a
c
i
s
s
o
s
m
t
s
s
s
c
r
i
a
N
A
X
n
T
o
c
d
w
d
o
o
e
h
f
e
w
r
t
a
C
I
i
w
t
C
T
R
A
B
B
B
C
C
C
C
C
D
d
D
D
d18  
tructure  (Farver  and  Pecht,  2011).  Such  proteins  are  also
ttractive  for  potential  uses  in  bioelectronic  systems,  which
an  be  studied  by  examining  their  conductance  properties
n  the  solid  state  (Ron  et  al.,  2010).
As  described  by  Tim  Clark,  a  problem  that  arises  in
imulating  electron  transport  is  that  the  processes  to  be
imulated  take  place  in  time  domains  that  differ  by  many
rders  of  magnitude.  For  example,  electronic  devices  con-
tructed  with  self-assembled  monolayers  of  ﬂexible  organic
olecules  need  to  be  coupled  with  very  much  faster  electron
ransport  through  the  system.  A  practical  approach  —  not
trictly  valid  but  giving  useful  results  in  practice  —  involves
imulation  of  electron  movement  on  static  snapshots  from
imulations  on  the  long  time  scale  of  the  conformational
hanges  (Leitherer  et  al.,  2014).  This  type  of  calculation
equires  the  power  of  modern  parallel  processing,  but  this
s  feasible  because  ‘‘a  smart  phone  today  has  the  power  of
 top-100  computer  of  1990’’.
anocrystallography
t  present  serial  femtosecond  nanocrystallography  allows
-ray  diffraction  snapshots  to  be  obtained  of  fully  hydrated
anocrystals  at  room  temperature  (Chapman  et  al.,  2011).
he  advantage  of  this  is  that  most  damage  processes  occur
n  much  longer  time  scales,  and  so  large  membrane  protein
omplexes  can  be  examined  before  they  have  had  time  to
isintegrate.  This  already  represents  a  major  advance  on
hat  was  possible  comparatively  recently,  but  it  has  the
isadvantage  that  the  Linac  Coherent  Light  Source  is  not
nly  an  extremely  expensive  piece  of  equipment,  but  it  also
ccupies  a  large  amount  of  space:  the  SLAC  National  Accel-
rator  Laboratory  in  California  is  about  3.2  km  in  length.  In
er  concluding  presentation  in  the  symposium  Petra  Fromme
oresaw  the  construction  in  the  next  few  years  of  an  accel-
rator  that  could  operate  in  the  attosecond  range  of  time,
ould  be  of  the  order  of  a  metre  in  length,  and  would  be
elatively  inexpensive  (by  the  standards  of  linear  accelera-
ors).  If  this  is  achieved  it  will  represent  a  huge  technological
dvance.
oncluding remarks
n  conclusion,  the  2014  Beilstein  Bozen  Symposium  on  Chem-
stry  and  Time  assembled  a  very  range  of  expert  lecturers
ho  were  very  successful  in  illustrating  the  importance  of
ime  at  many  different  levels  of  chemistry  and  biology.
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